摘要 |
The present invention provides a compound of Formula I: for use in the treatment, amelioration and/or prevention of diseases and conditions associated with CETP activity, such as atherosclerosis and dyslipidemia, in a subject with high triglyceride level; wherein R1, X1, R7, R5, C, L and p are defined herein. The present invention further provides a combination of pharmacologically active agents for use in the treatment, amelioration and/or prevention of diseases and conditions associated with CETP activity, such as atherosclerosis and dyslipidemia, in a subject with high triglyceride levels. |
申请人 |
NOVARTIS AG |
发明人 |
ARAI, YOSHIE;BROUSSEAU, MARGARET ELIZABETH;GU, JESSIE;HAYASHI, TOMOKO;MITANI, HIRONOBU;MOGI, MUNETO;NONOMURA, KAZUHIKO;YAMADA, KEN |